Moreover, the loss of muscle action potentials and increases of serum phosphorylated neurofilament levels were reversed by the SOD1 ASO, indicating a potential reversal of ALS symptoms. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.